###begin article-title 0
###xml 32 57 32 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schizosaccharomyces pombe</italic>
###xml 32 57 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
SUMO modification of Rad22, the Schizosaccharomyces pombe homologue of the recombination protein Rad52
###end article-title 0
###begin p 1
###xml 95 117 95 117 <email xmlns:xlink="http://www.w3.org/1999/xlink">f.z.watts@sussex.ac.uk</email>
To whom correspondence should be addressed. Tel: +44 1273 678257; Fax: +44 1273 678433; Email: f.z.watts@sussex.ac.uk
###end p 1
###begin p 2
###xml 4 35 4 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schizosaccharomyces pombe rad31</italic>
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5</italic>
###xml 291 297 291 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31 </italic>
###xml 301 305 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5</italic>
###xml 367 374 367 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 398 404 398 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31 </italic>
###xml 413 420 413 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5.62</italic>
###xml 1290 1297 1290 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1322 1338 1322 1338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe in&#160;vitro</italic>
###xml 1413 1421 1413 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 4 29 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 367 374 <span type="species:ncbi:4896">S.pombe</span>
###xml 613 626 <span type="species:ncbi:4896">fission yeast</span>
###xml 888 901 <span type="species:ncbi:4896">fission yeast</span>
###xml 1322 1329 <span type="species:ncbi:4896">S.pombe</span>
The Schizosaccharomyces pombe rad31 and hus5 genes are required for the DNA damage response, as mutants defective in these genes are sensitive to DNA damaging agents, such as UV and ionising radiation and to the DNA synthesis inhibitor hydroxyurea (HU). Sequence analysis has suggested that rad31 and hus5 encode components of the Pmt3 (SUMO) modification process in S.pombe. We show here that the rad31 null and hus5.62 mutants display reduced levels of Pmt3 modification. We have initiated a search for proteins required for the DNA damage response, which may be modified by Pmt3 and have identified Rad22, the fission yeast homologue of the recombination protein Rad52. Purification of myc + His-tagged Rad22 protein from cells expressing HA-tagged Pmt3 identifies an 83 kDa species which cross-reacts with anti-HA antisera. We show here that Rad22 interacts with Rhp51 and Rpa70 (the fission yeast homologues of Rad51 and the large subunit of RPA, respectively), but that neither of these proteins appears to be responsible for the 83 kDa species. The 83 kDa species is observed when extracts are prepared under both native and denaturing conditions, and is also observed when myc + His-tagged Rad22 and Pmt3 are expressed at wild type levels, suggesting that Rad22 is modified by Pmt3 in vivo. We have established an S.pombe in vitro Pmt3 modification system and have shown that Rad22 and Rhp51 are modified in vitro, but that Rpa70 is not.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 434 459 434 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schizosaccharomyces pombe</italic>
###xml 738 745 738 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 759 760 759 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c1">1</xref>
###xml 761 762 761 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c2">2</xref>
###xml 775 783 775 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe </italic>
###xml 820 825 820 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5 </italic>
###xml 829 834 829 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 920 921 920 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c3">3</xref>
###xml 922 923 922 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c4">4</xref>
###xml 1140 1147 1140 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5.62</italic>
###xml 1163 1168 1163 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 1351 1352 1351 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c3">3</xref>
###xml 1353 1354 1353 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c4">4</xref>
###xml 1392 1397 1392 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 1402 1406 1402 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5</italic>
###xml 1414 1415 1414 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c3">3</xref>
###xml 1416 1417 1416 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c5">5</xref>
###xml 1457 1462 1457 1462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 1467 1472 1467 1472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5 </italic>
###xml 419 432 <span type="species:ncbi:4896">fission yeast</span>
###xml 434 459 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 738 745 <span type="species:ncbi:4896">S.pombe</span>
###xml 775 782 <span type="species:ncbi:4896">S.pombe</span>
###xml 1497 1510 <span type="species:ncbi:4896">fission yeast</span>
The DNA damage response involves the coordination of a number of processes including DNA repair events and checkpoint arrest mechanisms. Defective DNA damage responses are identified as sensitivities to DNA damaging agents, such as UV and ionising radiation, or to the DNA synthesis inhibitor, hydroxyurea (HU). In mammalian cells, defects in the DNA damage response can lead to cancer or chromosome abnormalities. The fission yeast, Schizosaccharomyces pombe, has proved to be a good model for the characterisation of DNA damage response processes as analysis of mutants sensitive to radiation and to HU has identified many genes required either for repair of DNA damage or for the DNA integrity checkpoints, which are conserved between S.pombe and mammals (1,2). Among the S.pombe DNA damage response mutants are two, hus5 and rad31, which are epistatic to each other and which do not clearly define a repair process (3,4). Double mutant analysis indicates that the genes function in a process that also requires genes involved in the DNA integrity checkpoint, but they are not actually required for the activation of the checkpoint. The hus5.62 allele and the rad31 null mutant display morphological abnormalities including aberrant cell and nuclear morphology, sensitivity to UV and ionising radiation and a high rate of loss of mini-chromosomes (3,4). Comparison of the sequences of the rad31 and hus5 genes (3-5) with sequence databases suggests that rad31 and hus5 encode components of the fission yeast SUMO modification system.
###end p 4
###begin p 5
###xml 86 87 74 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c6">6</xref>
###xml 223 224 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c7">7</xref>
###xml 225 227 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c12">12</xref>
###xml 429 430 409 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c7">7</xref>
###xml 431 433 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c13">13</xref>
###xml 458 465 438 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 490 494 470 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pmt3</italic>
###xml 513 517 493 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pmt3</italic>
###xml 554 556 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c14">14</xref>
###xml 590 595 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 605 612 585 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5.62</italic>
###xml 443 456 <span type="species:ncbi:4896">fission yeast</span>
###xml 458 465 <span type="species:ncbi:4896">S.pombe</span>
 SUMO is a small ubiquitin-like modifier of approximately100 amino acids (reviewed in 6). It has been found complexed to a range of proteins, most of which are associated with the nucleus, e.g. PML, p53, IkappaBalpha (e.g. 7-12). The role of SUMO modification has not been fully identified, but is likely to include roles in facilitating protein-protein interactions and alterations in the nuclear localisation of proteins (e.g. 7,13). In the fission yeast, S.pombe, SUMO is encoded by the pmt3 gene. Deletion of pmt3 results in a pleiotropic phenotype (14) similar to that observed in the rad31 null and hus5.62 strains, consistent with multiple roles for SUMO modification.
###end p 5
###begin p 6
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c15">15</xref>
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c6">6</xref>
###xml 393 417 393 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 446 450 446 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AOS1</italic>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UBA2 </italic>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c16">16</xref>
###xml 501 505 501 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UBC9</italic>
###xml 507 508 507 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c5">5</xref>
###xml 613 618 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 620 621 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c4">4</xref>
###xml 627 632 627 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fub2 </italic>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c14">14</xref>
###xml 672 677 672 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> hus5</italic>
###xml 679 680 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c3">3</xref>
###xml 692 693 692 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f1">1</xref>
###xml 721 733 721 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 733 738 733 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AOS1 </italic>
###xml 794 800 794 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31 </italic>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c16">16</xref>
###xml 822 827 822 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 844 845 844 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c4">4</xref>
###xml 393 417 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 514 527 <span type="species:ncbi:4896">fission yeast</span>
 SUMO modification of proteins requires initial processing of precursor SUMO to the mature form to reveal a GG motif necessary for conjugation to target proteins (e.g. 15). Mature SUMO is then activated by attachment to a protein heterodimer (described below), before transfer to a conjugator protein, which in turn is responsible for attachment of SUMO to target proteins (reviewed in 6). In Saccharomyces cerevisiae the activator is encoded by AOS1 and UBA2 (16), while the conjugator is encoded by UBC9 (5). In fission yeast, sequence comparisons indicate that the likely homologues to the activator genes are rad31 (4) and fub2 (14), while the conjugator is encoded by hus5 (3) (see Fig. 1A). In support of this, the S.cerevisiaeAOS1 gene, which has a high degree of sequence similarity to rad31 (16), complements the rad31 null phenotype (4).
###end p 6
###begin p 7
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c17">17</xref>
###xml 376 388 376 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c18">18</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c19">19</xref>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c20">20</xref>
###xml 190 195 <span type="species:ncbi:4932">yeast</span>
###xml 376 388 <span type="species:ncbi:4932">S.cerevisiae</span>
 Two highly conserved recombination proteins, Rad51 and Rad52, interact with either SUMO-1 (one of the mammalian SUMO proteins) or components of the SUMO-1 modification machinery. Using the yeast two-hybrid system, mammalian Rad51 was demonstrated to interact with SUMO-1 (17). In separate screens, the mammalian Rad51 and Rad52 proteins were found to interact with Ubc9, the S.cerevisiae Smt3 conjugator (18,19). More recently both Rad51 and Rad52 have been shown to co-immunoprecipitate with SUMO-1 and UBC9 (20). Conjugation of SUMO-1 to either of these proteins was not detected.
###end p 7
###begin p 8
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c21">21</xref>
###xml 319 327 319 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c22">22</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c23">23</xref>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c24">24</xref>
###xml 556 561 556 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad51</italic>
###xml 566 571 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad52</italic>
###xml 600 605 600 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhp51</italic>
###xml 610 615 610 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad22</italic>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c25">25</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c27">27</xref>
###xml 846 851 846 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhp51</italic>
###xml 132 137 <span type="species:ncbi:4932">yeast</span>
###xml 524 537 <span type="species:ncbi:4896">fission yeast</span>
 Rad51 and Rad52 have major roles in genetic recombination and in the repair of double strand DNA breaks. The mammalian and budding yeast Rad51 and Rad52 proteins have been purified and their activities characterised. Rad51 is a structural and functional homologue of RecA and is required for DNA strand exchange (21). In vitro studies suggest that Rad52, along with RPA, promotes the strand exchange activity of Rad51 (22). Rad52 has been shown to function as a heptameric ring (23) and to bind resected DNA ends (24). The fission yeast homologues of the rad51 and rad52 genes have been cloned [the rhp51 and rad22 genes, respectively (25-27)], but little is known about the activities or interactions of the gene products. Deletion of either gene results in a high degree of sensitivity to both UV and ionising radiation and in the case of the rhp51 null allele, a slow growth phenotype, indicating major roles in normal cell growth as well as in the repair of damage due to exposure to DNA damaging agents.
###end p 8
###begin p 9
###xml 38 44 38 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31 </italic>
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> hus5 </italic>
###xml 91 98 91 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 436 443 436 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 595 603 595 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 634 641 634 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 91 98 <span type="species:ncbi:4896">S.pombe</span>
###xml 210 223 <span type="species:ncbi:4896">fission yeast</span>
###xml 436 443 <span type="species:ncbi:4896">S.pombe</span>
###xml 634 641 <span type="species:ncbi:4896">S.pombe</span>
 In this report we first confirm that rad31 and hus5 are required for Pmt3 modification in S.pombe. We also describe some results of a search for DNA damage response proteins likely to be modified by Pmt3, the fission yeast homologue of SUMO-1. One of the proteins we have identified is Rad22. We have analysed the interactions between Rad22 and Pmt3, as well as between Rad22 and other DNA metabolism proteins, specifically Rhp51 (the S.pombe homologue of Rad51) and Rpa70, the large subunit of RPA. To facilitate the investigation into whether Rad22 is modified by Pmt3 we have established an in vitro SUMO modification system from S.pombe protein components and used this to determine whether Rad22 or the proteins with which it interacts are modified by Pmt3.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
Strains and plasmids
###end title 11
###begin p 12
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 52 60 52 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade6.704</italic>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ura4</italic>
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D18</italic>
###xml 72 79 72 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">leu1.32</italic>
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 82 83 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 94 105 94 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31::ura4</italic>
###xml 107 115 107 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade6.704</italic>
###xml 117 124 117 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">leu1.32</italic>
###xml 126 134 126 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ura4.D18</italic>
###xml 136 137 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 137 138 137 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 149 156 149 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5.62</italic>
###xml 158 166 158 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade6.704</italic>
###xml 168 175 168 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">leu1.32</italic>
###xml 177 185 177 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ura4.D18</italic>
###xml 187 188 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 188 189 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad22</italic>
###xml 207 211 207 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ura4</italic>
###xml 213 220 213 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">leu1.32</italic>
###xml 222 230 222 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade6.704</italic>
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 231 232 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c26">26</xref>
###xml 255 267 255 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mycHis-rad22</italic>
###xml 276 284 276 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade6.704</italic>
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ura4</italic>
###xml 291 294 291 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D18</italic>
###xml 296 303 296 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">leu1.32</italic>
###xml 305 306 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 306 307 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;</sup>
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad22</italic>
###xml 501 506 501 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad22</italic>
###xml 565 570 565 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad22</italic>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c26">26</xref>
###xml 625 630 625 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad22</italic>
###xml 744 749 744 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad22</italic>
###xml 776 779 776 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nde</italic>
###xml 818 820 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c28">28</xref>
###xml 873 879 873 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad22 </italic>
###xml 927 932 927 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad22</italic>
###xml 997 999 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c29">29</xref>
###xml 1090 1096 1090 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad22 </italic>
###xml 1348 1364 1348 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 1369 1374 1369 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad22</italic>
###xml 1432 1436 1432 1436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pmt3</italic>
###xml 1570 1575 1570 1575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhp51</italic>
###xml 1766 1771 1766 1771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhp51</italic>
###xml 1791 1797 1791 1797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rpa70 </italic>
###xml 1850 1852 1850 1852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c30">30</xref>
###xml 1859 1864 1859 1864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad22</italic>
###xml 1866 1871 1866 1871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rhp51</italic>
###xml 1876 1881 1876 1881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rpa70</italic>
###xml 1909 1912 1909 1912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nde</italic>
###xml 1914 1917 1914 1917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 2079 2080 2079 2080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c8">8</xref>
###xml 2081 2082 2081 2082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c9">9</xref>
###xml 2089 2096 2089 2096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 2134 2136 2134 2136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c31">31</xref>
###xml 2162 2164 2162 2164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c28">28</xref>
###xml 2353 2356 2353 2356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nde</italic>
###xml 2362 2365 2362 2365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 4 11 <span type="species:ncbi:4896">S.pombe</span>
###xml 1023 1030 <span type="species:ncbi:4896">S.pombe</span>
###xml 1348 1364 <span type="species:ncbi:562">Escherichia coli</span>
###xml 2089 2096 <span type="species:ncbi:4896">S.pombe</span>
The S.pombe strains used in this study were sp.011 (ade6.704, ura4.D18, leu1.32, h-), sp.333 (rad31::ura4, ade6.704, leu1.32, ura4.D18, h-), sp.376 (hus5.62, ade6.704, leu1.32, ura4.D18, h+), sp.424 [rad22::ura4, leu1.32, ade6.704h+ (26)] and sp.568 (int mycHis-rad22/pSTA18, ade6.704, ura4.D18, leu1.32, h-). sp.568 was created by first amplifying the rad22 coding sequence by PCR from genomic DNA using the following primers: 5'-AAGCTAGAACATATGTCTTTTGAGCAA and 5'-TTTGCCTGGATCCTTTTATCCTTTTTTGG. The rad22 coding sequence was checked for ability to complement the rad22 disruption strain (26). The 5' upstream region of the rad22 gene was amplified using primers 5'-AAGTATGGACCATGGGCTT and 5'-CAAAAGACATATGTTCTAGCT, and cloned upstream of the rad22 coding sequence. A 100 bp NdeI fragment containing 2x myc + 6x His (28) was inserted between the promoter fragment and the rad22 coding sequence. The promoter-containing tagged rad22 sequence was then subcloned into the integrating vector pSTA18 (29) and used to transform S.pombe sp.011 cells to adenine prototrophy. The integrated tagged rad22 strain was analysed to ensure that there was no phenotype such as altered cell or nuclear morphology, rate of cell growth or cell viability, or alterations in the DNA damage response, due to the presence of the myc + His tag. For expression studies in Escherichia coli the rad22 ORF was subcloned into pET15b (Novagen). The full-length pmt3 coding sequence was amplified by PCR using the following primers: SEN4, CTGTGAACATATGTCTCATG; and Pmt3-4, TGGAGAGGATCCACGTATTGG. The rhp51 coding sequence was amplified by PCR using the following primers: r51a, TAACAAGTTACCATGGCAGATA; and r51b, TAGGATCCTTTAGACAGGTGCGAT, and checked for function by its ability to complement the rhp51 null mutation. The rpa70 coding sequence was a gift from A. M. Carr (Sussex) (30). The rad22, rhp51 and rpa70 ORFs were all amplified as NdeI-BamHI fragments to allow subsequent cloning into the appropriate expression vectors. The PML wild type and mutant ORFs cloned into pSG5 were gifts from F. Lehembre (8,9). The S.pombe expression vectors used were pREP41 (31), pREP41HA and pREP42MH (28); pREP41HA and pREP42MH contain a haemagglutinin tag and 2x myc + 6x His tags, respectively, and were used to produce in-frame protein fusions by insertion of coding sequences between the Nde1 and BamHI sites of the two vectors.
###end p 12
###begin title 13
Protein extraction and immunological methods
###end title 13
###begin p 14
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> et al</italic>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c32">32</xref>
###xml 77 79 77 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 257 258 257 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 322 323 322 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 392 394 392 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 534 535 534 535 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 695 697 692 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 741 743 738 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Whole cell TCA extracts were prepared as described by Caspari et al. (32). Ni2+ affinity chromatography was undertaken under either non-denaturing or denaturing conditions. The non-denaturing conditions were those described by Novagen with the inclusion of N-ethylmaleimide (10 mM), iodoacetamide (10 mM), NaF (50 mM), NaN3 (10 mM) and mammalian protease inhibitor cocktail (Sigma) (0.2%). Ni2+ affinity purification under denaturing conditions was carried out as follows: cells were lysed into buffer A (6 M guanidine-HCl, 0.1 M NaPO4 buffer, 0.01 M Tris pH 8.0, 5 mM imidazole, 10 mM beta-mercaptoethanol) and insoluble material removed by centrifugation. The supernatant was incubated with Ni2+ agarose for 2 h at room temperature. The Ni2+ agarose was then washed in buffer A, followed by buffer B (as buffer A with 8 M urea instead of guanidine-HCl), then in Novagen wash buffer plus 6 M urea, 20 mM imidazole and protein was eluted in 6 M urea, 300 mM imidazole.
###end p 14
###begin p 15
 The Rad22-Hus5 interaction was investigated by mixing two bacterial cell lysates of 50 ml cultures expressing His-Rad22 (from pET15b) and GST-Hus5 (from pGEX) and purification of the GST-Hus5 protein using glutathione-Sepharose beads (Pharmacia) as described by the manufacturers, followed by SDS-PAGE.
###end p 15
###begin p 16
 Anti-Pmt3 antisera were produced using a His-tagged fusion protein of an N-terminally truncated version of Pmt3 (NDeltaPmt3) created by PCR using oligonucleotides Pmt3-1 (CTGAGAACATATGTCTGAATCACC) and Pmt3-4. Anti-ubiquitin antisera were obtained from DAKO, anti-myc antisera were from RDI Inc., anti-HA antisera were from Babco and anti-His antisera were from Pharmacia.
###end p 16
###begin title 17
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
In vitro SUMO-1 modification assay
###end title 17
###begin p 18
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 63 64 63 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c4">4</xref>
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fub2 </italic>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5 </italic>
###xml 376 382 376 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 780 782 780 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 862 870 862 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 946 947 946 947 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1139 1141 1123 1125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 376 382 <span type="species:ncbi:562">E.coli</span>
Amplification of the rad31 cDNA has been described previously (4). The fub2 ORF was amplified by PCR using the following oligonucleotide primers: Uba2p-N, CATATGCCAAGGCTAATGCAAC; and Uba2p-B, GGATCCAAATGGTTTATTTACATAG. The hus5 ORF was a gift from A. M. Carr (Sussex). The ORFs were cloned into pGEX and Rad31, Fub2 and Hus5 proteins were purified as GST fusion proteins from E.coli. The GST was cleaved off the GST-Hus5 fusion using thrombin (5 U/mg protein) and Hus5 was purified by passage over glutathione-Sepharose. Pmt3-GG, a C-terminally truncated version of Pmt3 equivalent to the mature form was produced with an N-terminal His tag and was constructed by PCR using oligonucleotides SEN4 and Sumo-GG (GGATCCTAAGGAGGTAACTGTTCT). Radio-labelled proteins were produced with [35S]methionine using the TnT T7 coupled reticulocyte lysate system (Promega). The in vitro Pmt3 modification assay was carried out in 50 mM Tris-HCl pH 7.5, 5 mM MgCl2, 5 mM ATP, 10 mM creatine phosphate, 3.5 U/ml creatine kinase, 0.6 U/ml inorganic pyrophosphatase using 3 microg Hus5, 10 microg His-Pmt3, 0.5 microg SAE1 (GST-Rad31 + GST-Fub2) and 2 microl 35S-labelled protein from the TnT reaction at 30degreesC for 2 h. Reactions were analysed by SDS-PAGE followed by analysis on a phosphorimager.
###end p 18
###begin title 19
RESULTS
###end title 19
###begin title 20
###xml 21 28 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 21 28 <span type="species:ncbi:4896">S.pombe</span>
Pmt3 modification of S.pombe proteins
###end title 20
###begin p 21
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5</italic>
###xml 74 81 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 288 295 288 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5.62</italic>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f1">1</xref>
###xml 543 548 543 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 558 565 558 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5.62</italic>
###xml 592 597 592 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 602 606 602 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5</italic>
###xml 669 674 669 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 684 691 684 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5.62</italic>
###xml 747 748 747 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f1">1</xref>
###xml 768 773 768 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 778 782 778 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5</italic>
###xml 864 869 864 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 1026 1031 1026 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 1108 1115 1108 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5.62</italic>
###xml 1198 1199 1198 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c3">3</xref>
###xml 74 81 <span type="species:ncbi:4896">S.pombe</span>
Sequence comparisons suggest that rad31 and hus5 encode components of the S.pombe Pmt3 (SUMO) modification process. To confirm that the Rad31 and Hus5 proteins are actually required for Pmt3 modification, we first wished to investigate the levels of Pmt3-conjugates in the rad31 null and hus5.62 mutant strains. Anti-Pmt3 antisera were prepared as described in the Materials and Methods. Figure 1B shows that they are specific for Pmt3 and do not cross-react with ubiquitin. We next compared the pattern of Pmt3-modified species in wild type, rad31 null and hus5.62 mutant cells. Analysis of rad31 and hus5 mutant cells indicates a decrease in modified species in both rad31 null and hus5.62 strains with a concomitant increase in free Pmt3 (Fig. 1C), confirming that rad31 and hus5 have roles in Pmt3 conjugation. The low residual level of Pmt3-conjugates in the rad31 null mutant most likely results from the activity of Fub2 which contains the conserved cysteine residue that forms a thiolester bond with Pmt3. Deletion of rad31 may not, therefore, completely abolish the activity of Fub2. In the case of hus5.62, this allele has previously been shown to be a partial loss-of-function mutation (3) and presumably allows a low level of Pmt3 conjugation.
###end p 21
###begin p 22
###xml 447 454 447 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 651 653 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c20">20</xref>
###xml 447 454 <span type="species:ncbi:4896">S.pombe</span>
 We next wished to determine whether exposure of cells to ionising radiation or HU affected the overall pattern of Pmt3-conjugates in wild type cells. We therefore subjected cells to ionising radiation (500 Gy) or HU (20 mM for 3 h), prior to protein extraction and western analysis. We did not detect any major differences after exposure to any of the conditions that we tested (data not shown). We also tested whether over-expression of Pmt3 in S.pombe cells affected the resistance of cells to UV or ionising radiation [as over-expression of SUMO-1 has been shown to result in a decrease in the resistance of mammalian cells to ionising radiation (20)]. Cells over-expressing either tagged or untagged Pmt3, using pREP41HA and pREP41, respectively, or an untagged truncated version of Pmt3 (Pmt3-GG), using pREP41, displayed similar sensitivities to UV and ionising radiation as wild type cells transformed with empty vector (data not shown).
###end p 22
###begin title 23
Search for Pmt3-associated proteins identifies Rad22 as a likely candidate
###end title 23
###begin p 24
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5</italic>
###xml 507 509 507 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 658 665 658 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 693 694 693 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f2">2</xref>
###xml 658 665 <span type="species:ncbi:4896">S.pombe</span>
The fact that the rad31 and hus5 mutants are sensitive to UV, ionising radiation and HU suggests that Pmt3 modification is required for some aspect(s) of the DNA damage response. We therefore sought to identify Pmt3-modified targets likely to have a role in the DNA damage response. We screened a number of DNA damage response proteins for interaction with Pmt3 by over-expressing them as myc + His-tagged fusion proteins in cells also over-expressing HA-tagged Pmt3, followed by affinity purification on Ni2+ agarose. The characterisation of some of these genes will be described elsewhere. One of the proteins we investigated in more detail was Rad22, the S.pombe homologue of Rad52. Figure 2A (lane 3) shows that indeed Rad22 and Pmt3 interact as a new HA-tagged (i.e. Pmt3-modified) 83 kDa species is detected when both proteins are over-expressed. This species is not detected when either HA-Pmt3 (lane 1) or myc + His-Rad22 (lane 2) are expressed on their own. The presence of two bands in lanes 2 and 3 after blotting with anti-myc antisera is likely to be due to proteolysis as only a single species, corresponding to the upper band is observed in the TCA extracts (lanes 6 and 7). The size of the species observed in lane 3 (approximately83 kDa) is consistent with that expected of an HA-Pmt3-modified form of myc + His-Rad22.
###end p 24
###begin p 25
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad22</italic>
###xml 127 128 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f2">2</xref>
###xml 231 238 231 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 231 238 <span type="species:ncbi:4896">S.pombe</span>
 No gross differences in Pmt3-modified species are observed in whole cell TCA extracts of wild type and rad22 null cells (Fig. 2A, lanes 4 and 5), indicating that the 83 kDa species is not one of the major Pmt3-modified species in S.pombe.
###end p 25
###begin p 26
###xml 59 60 59 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f2">2</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c33">33</xref>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c34">34</xref>
###xml 629 630 629 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f2">2</xref>
###xml 856 857 844 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f2">2</xref>
###xml 1105 1106 1081 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f2">2</xref>
###xml 1295 1296 1271 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f2">2</xref>
 It is possible that the 83 kDa species observed in Figure 2A might be an HA-Pmt3-modified form of a protein that interacts with Rad22, rather than Pmt3-modified Rad22. To determine whether this might be the case, we investigated whether Rad22 interacted with two possible candidates, Rhp51 and Rpa70. Rhp51 and Rpa70 are the homologues of Rad51 and the large subunit of the single strand DNA binding protein (RPA) which, in other organisms, have been shown to interact with Rad52, the homologue of Rad22 (33,34). Myc + His-tagged Rad22 was, therefore, over-expressed along with either HA-tagged Rhp51 or HA-tagged Rpa70. Figure 2B (lane 2) shows that Rad22 interacts with Rhp51 as observed by the approximately60 kDa species present in lane 2, but which is not present in the negative controls (lanes 1 and 3). Similarly, Rad22 interacts with Rpa70 (Fig. 2C, lane 2) with a species of approximately72 kDa pulled down specifically with myc + His-tagged Rad22, and which is not observed in the absence of HA-Rpa70 (lane 1) or myc + His-Rad22 (lane 3). The sizes of the HA-tagged species detected in Figure 2B and C are as expected for tagged, but unmodified, forms of Rhp51 and Rpa70 proteins, respectively, and are distinctly smaller than the 83 kDa Pmt3-associated species identified in Figure 2A, as they migrate at 60 and 72 kDa, respectively. These data suggest that although Rad22 interacts with both Rhp51 and Rpa70, neither of these proteins is likely to be a candidate for an 83 kDa Pmt3-modified Rad22-interacting protein.
###end p 26
###begin title 27
Further analysis of the interaction between Rad22 and components of the Pmt3 modification process
###end title 27
###begin p 28
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f2">2</xref>
###xml 391 400 391 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 444 445 444 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f3">3</xref>
###xml 496 504 496 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
As analysis of the interactions of Rad22 with Rhp51 and Rpa70 suggests that neither Rhp51 nor Rpa70 appears to be responsible for the 83 kDa species detected in Figure 2A, we wished to further analyse the relationship between Rad22 and Pmt3 and with components of the Pmt3 modification process. We first investigated whether Rad22 interacts with the Pmt3 conjugator, Hus5. This was analysed in vitro using GST-Hus5 and His-tagged Rad22. Figure 3A shows that GST-Hus5 interacts with Rad22 protein in vitro, as Rad22 is pulled down with GST-Hus5 using glutathione-Sepharose (lane 2), but not in the absence of Hus5 (lanes 1 and 2). The relative amount of Rad22 which purifies with Hus5 (lane 2) and which remains in the supernatant is low (lane 8), suggesting that the interaction between Rad22 and Hus5 is transient in nature.
###end p 28
###begin p 29
###xml 158 160 158 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f2">2</xref>
###xml 327 328 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f3">3</xref>
 To further investigate whether Rad22 is modified by Pmt3, we wished to establish whether HA-Pmt3 is associated with Rad22 under denaturing conditions. The Ni2+ pull down assay described in Figure 2A was, therefore, repeated in the presence of guanidine-HCl which would be expected to disrupt non-covalent interactions. Figure 3B shows that the 83 kDa species is still pulled down with the myc + His-Rad22 protein (lane 2), but not when Rad22 or Pmt3 are over-expressed alone (lanes 1 and 3), implying that Rad22 is modified by HA-Pmt3.
###end p 29
###begin p 30
###xml 143 151 143 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 210 211 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f2">2</xref>
###xml 217 218 217 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f3">3</xref>
###xml 301 308 301 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 366 371 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad22</italic>
###xml 388 390 388 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 450 451 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f3">3</xref>
###xml 301 308 <span type="species:ncbi:4896">S.pombe</span>
 The interactions observed so far between Rad22 and Pmt3 or Hus5 have been either under conditions where Rad22 and Pmt3 are over-expressed, or in vitro. To confirm that the 83 kDa species we observe in Figures 2A and 3B is not an artefact due to over-expression of either Rad22 or Pmt3, we created an S.pombe strain containing an integrated myc + His-tagged copy of rad22, repeated the Ni2+ pull down assay and probed with anti-Pmt3 antisera. Figure 3C shows that the 83 kDa species is observed in cells expressing wild type levels of both Rad22 and Pmt3 (lane 5), but not in the control sample (lane 6). The level of the 83 kDa species is low in comparison to the amount of myc + His-tagged Rad22 pulled down in this experiment (note the different exposure times of lanes 5 and 6 compared with that of the other lanes). The bands observed in lane 5 were visible at the exposure time used for lanes 1-4, but were faint. In addition to the 83 kDa species, an additional species at approximately110 kDa is also observed. The identity of this is unknown, but its size is consistent with it being Rad22-modified by two Pmt3 molecules. Our inability to detect the 83 kDa species in anti-myc blots may reflect masking of the myc epitope by the Pmt3 modification of the different affinities of the anti-myc and anti-HA antisera.
###end p 30
###begin title 31
###xml 25 33 25 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Rad22 is SUMO-1-modified in vitro
###end title 31
###begin p 32
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 371 379 371 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 411 418 411 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 482 483 482 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f4">4</xref>
###xml 575 587 575 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 736 744 736 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 831 832 831 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f4">4</xref>
###xml 1102 1109 1102 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli </italic>
###xml 411 418 <span type="species:ncbi:4896">S.pombe</span>
###xml 575 587 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 1102 1108 <span type="species:ncbi:562">E.coli</span>
The results of the analysis of Rad22 in vivo are strongly suggestive that Rad22 is modified by Pmt3. However, as Pmt3 modification is difficult to observe in cells because the modification appears to be labile and Pmt3-modified species are present at a low level, we wished to use a further method for analysing Pmt3 modification of proteins. We therefore established an in vitro Pmt3 modification system using S.pombe components (as described in the Materials and Methods). Figure 4A shows the protein components that were purified for use in the assay. By analogy with the S.cerevisiae and mammalian homologues it was presumed that Pmt3 needs to be processed to reveal the GG motif for conjugation onto target proteins. Thus, for the in vitro system we prepared His-tagged Pmt3-GG as described in the Materials and Methods (Fig. 4, lane 2). Several procedures were tested for the preparation of the activator (Rad31 + Fub2) and the conjugator (Hus5) with the result that we obtained maximum yields of soluble protein by preparing the three proteins as GST fusion proteins. Rad31- and Fub2-containing E.coli extracts were mixed together prior to purification on glutathione-Sepharose as this prevented precipitation of the individual proteins. The GST moiety was removed from Hus5, but not from Rad31 and Fub2.
###end p 32
###begin p 33
###xml 5 21 5 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe in vitro</italic>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f4">4</xref>
###xml 569 577 569 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c12">12</xref>
###xml 5 12 <span type="species:ncbi:4896">S.pombe</span>
 The S.pombe in vitro Pmt3 modification system was first tested using the well established mammalian SUMO-1 target protein, PML. Figure 4B shows that the system is capable of modifying wild type PML protein (lanes 1 and 2), but not an unmodifiable version of it (lane 8). The modification is dependent on the presence of Rad31, Fub2 and Hus5 as omission of any one of these components results in loss of the modification (lanes 3-5, 7 and 9). Omission of added ATP did not prevent the reaction. This appears to be in contrast to what has been observed in the mammalian in vitro SUMO-1 modification system (12), but is likely to be due to the presence of ATP in the reticulocyte lysate used here to create labelled substrates.
###end p 33
###begin p 34
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in&#160;vitro</italic>
###xml 81 82 81 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f4">4</xref>
###xml 133 141 133 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 253 261 253 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f3">3</xref>
###xml 299 306 299 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in&#160;vivo</italic>
###xml 376 384 376 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 603 604 603 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f3">3</xref>
###xml 419 424 <span type="species:ncbi:4932">yeast</span>
 We next investigated whether Rad22 was modified in this in vitro system. Figure 4C (lane 1) indicates that Rad22 is indeed modified in vitro. The size of the major modified species corresponds well with the size of the Pmt3-associated species observed in vivo (e.g. Fig. 3C). (The species detected in vivo would be expected to migrate slightly slower than the forms detected in vitro as the Rad22 species expressed in yeast contains two additional myc epitopes.) There is also a very minor species at 105 kDa which migrates with similar relative molecular mass to the larger species observed in Figure 3C, lane 5. As with PML, the modification of Rad22 is dependent on the presence of added SAE (Rad31 + Fub2), Hus5 and Pmt3 (lanes 2-4).
###end p 34
###begin p 35
###xml 85 94 85 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> in vitro</italic>
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f4">4</xref>
###xml 159 167 159 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 209 210 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f4">4</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f4">4</xref>
 We also investigated whether proteins which interact with Rad22 are modified by Pmt3 in vitro. Figure 4D, lanes 1 and 2, shows that Rhp51 is modified by Pmt3 in vitro, while Rpa70 does not appear to be (Fig. 4E, lanes 1 and 2). Modification of Rhp51 is dependent on the presence of added Hus5 and SAE (Rad31 + Fub2) (Fig. 4D, lanes 3-5).
###end p 35
###begin title 36
DISCUSSION
###end title 36
###begin p 37
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5</italic>
###xml 130 137 130 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 179 196 179 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe in vitro </italic>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c8">8</xref>
###xml 503 511 503 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe </italic>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c12">12</xref>
###xml 800 808 800 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in&#160;vitro</italic>
###xml 841 849 841 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe </italic>
###xml 1022 1024 1022 1024 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 1369 1375 1369 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 130 137 <span type="species:ncbi:4896">S.pombe</span>
###xml 179 186 <span type="species:ncbi:4896">S.pombe</span>
###xml 503 510 <span type="species:ncbi:4896">S.pombe</span>
###xml 841 848 <span type="species:ncbi:4896">S.pombe</span>
###xml 972 978 <span type="species:ncbi:9986">rabbit</span>
###xml 1230 1235 <span type="species:ncbi:4565">wheat</span>
###xml 1369 1375 <span type="species:ncbi:562">E.coli</span>
We have confirmed here our speculation, derived from sequence comparisons, that the rad31 and hus5 genes encode components of the S.pombe SUMO-1 (Pmt3) conjugation machinery. The S.pombe in vitro Pmt3 modification system, which we describe and which uses purified Rad31, Fub2 and Hus5 enzymes, is capable of modifying the mammalian protein PML, but not a mutant version of it that has been shown in the mammalian SUMO-1 modification system to be unmodifiable (8). The levels of Pmt3 modification in the S.pombe system, while low, resemble the levels of SUMO-1 modification observed using the mammalian system (e.g. 12). The Pmt3 modification that we detect requires the presence of added Pmt3-GG (the mature form of Pmt3), the activator (Rad31 + Fub2) and the conjugator, Hus5. As with the mammalian in vitro SUMO-1 modification system, the S.pombe system does not appear to require a Pmt3 ligase, although it is possible that such an activity might be contributed by the rabbit reticulocyte lysate system used to prepare 35S-labelled substrates. We have obtained similar results using substrates labelled in the TnT wheatgerm system (data not shown), indicating that if a Pmt3 ligase is required it is also being provided by the wheat- germ extract. A Pmt3 ligase is unlikely to have co-purified with any of the modification components, as they were all prepared from E.coli, which does not have ubiquitin or ubiquitin-like proteins.
###end p 37
###begin p 38
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5.62</italic>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c35">35</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c36">36</xref>
###xml 377 382 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31</italic>
###xml 384 388 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5</italic>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pmt3</italic>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c3">3</xref>
###xml 416 417 416 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c4">4</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c14">14</xref>
###xml 860 861 860 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f3">3</xref>
###xml 927 928 927 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f3">3</xref>
###xml 1183 1184 1171 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f3">3</xref>
###xml 1457 1459 1445 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c37">37</xref>
 The UV, ionising radiation and HU sensitivities of the rad31 null and hus5.62 mutants imply that Pmt3 modification has a role in one or more aspects of the DNA damage response. Previous work on SUMO-1 has shown that the majority of SUMO-1-modified proteins are located within the nucleus (35), although there are exceptions to this (e.g. 36). The range of defects observed in rad31, hus5 and pmt3 mutant strains (3,4,14) suggest that there are likely to be several, or possibly many, proteins involved in aspects of DNA metabolism or the DNA damage response which have their function modulated by Pmt3 modification. Among a number of DNA damage response proteins we have tested, we identified Rad22 as a potential Pmt3-modified target. Taken together, the data described here, in particular the interaction of Rad22 and Pmt3 under denaturing conditions (Fig. 3B) and when both proteins are expressed at wild type levels (Fig. 3C), strongly suggest that Rad22 is modified by Pmt3. From these experiments we estimate that the level of the modified species is approximately2-5% of the level of the unmodified Rad22 protein. The presence of two Pmt3-modified species observed in Figure 3C may indicate that Rad22 is modified by two Pmt3 molecules. The majority of the cases of multiple sumoylation have been shown to be due to single SUMO-1 molecules attached to multiple sites. However, there is a recent report of SUMO-2 and SUMO-3 forming polymeric chains (37). Whether Pmt3 is able to form chains remains to be determined.
###end p 38
###begin p 39
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 148 155 148 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 353 354 353 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f2">2</xref>
###xml 509 516 509 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 619 627 619 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 681 688 681 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 757 764 757 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 946 953 946 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 979 986 979 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 986 994 986 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1163 1170 1163 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 757 764 <span type="species:ncbi:4896">S.pombe</span>
 In addition to Rad22, the in vitro Pmt3 modification system is also capable of modifying Rhp51. However, in contrast to what we observe with Rad22 in vivo, we have not detected any species which might correspond to Pmt3-modified Rhp51 when, for example, we over-express myc + His-Rhp51 and HA-Pmt3 under similar conditions to those described in Figure 2. The reason for this is not known but may be due to the presence of very low levels of Pmt3-modified Rhp51 or that Pmt3-modified Rhp51 is highly unstable in vivo. The fact that we do not detect modification of Rpa70 indicates that not all substrates tested in the in vitro system give positive results. During these and other in vivo studies that we have undertaken to investigate Pmt3 modification of S.pombe proteins, we have found Pmt3-modified species to be present at low levels and difficult to purify from cell extracts. This makes the task of identifying novel Pmt3-modified targets in vivo a laborious process. The S.pombein vitro Pmt3 modification system will thus provide a useful and relatively straightforward first step in the identification of potential Pmt3 targets, which can then be tested in vivo.
###end p 39
###begin p 40
###xml 193 195 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gke550c12">12</xref>
###xml 604 605 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f2">2</xref>
###xml 610 611 594 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gke550f3">3</xref>
 Multiple possible roles have been proposed for SUMO-1 modification. One of these is demonstrated in the case of IkappaBalpha, where SUMO-1 competes with ubiquitin for the same lysine residue (12). SUMO-1 modification of IkappaBalpha prevents ubiquitination and hence protects the protein from degradation by the proteasome. We have no direct evidence that Rad22 is ubiquitinated or is subject to ubiquitin-dependent proteolysis. However, Rad22 is somewhat unstable in cell extracts, even in the presence of the mammalian protease inhibitor cocktail as can be observed by the doublet of bands in Figures 2 and 3. The upper band corresponds to the band seen in TCA extracts, with the lower species likely to be a degradation product. Alternatively Pmt3 modification of Rad22 might affect the location of Rad22 within cells or within distinct compartments within the nucleus or might alter its ability to interact with different proteins.
###end p 40
###begin title 41
Figures and Tables
###end title 41
###begin p 42
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe</italic>
###xml 32 33 32 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 75 87 75 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 91 99 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> S.pombe</italic>
###xml 131 143 131 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.cerevisiae</italic>
###xml 197 198 197 198 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 483 484 475 476 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 592 599 584 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad31.d</italic>
###xml 620 627 612 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hus5.62</italic>
###xml 22 29 <span type="species:ncbi:4896">S.pombe</span>
###xml 75 87 <span type="species:ncbi:4932">S.cerevisiae</span>
###xml 92 99 <span type="species:ncbi:4896">S.pombe</span>
###xml 131 143 <span type="species:ncbi:4932">S.cerevisiae</span>
 Pmt3 modification in S.pombe. (A) Schematic showing the components of the S.cerevisiae and S.pombe Pmt3 modification pathway. The S.cerevisiae nomenclature is taken from previous studies (5,16). (B) Anti-Pmt3 antisera are specific for Pmt3 and do not recognise ubiquitin. NDeltaPmt3 (lanes 1 and 3) and ubiquitin (0.5 microg) (lanes 2 and 4) were separated by SDS-PAGE (12.5%) and western blotted with anti-Pmt3 antisera (lanes 1 and 2) or anti-ubiquitin antisera (lanes 3 and 4). (C) SDS-PAGE and western blotting with anti-Pmt3 antisera of protein extracts from wild type (sp.011) lane 1, rad31.d (sp.333) lane 2 and hus5.62 (sp.376) lane 3.
###end p 42
###begin p 43
###xml 51 52 51 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 78 79 78 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 106 107 106 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 287 291 287 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nmt1</italic>
###xml 349 351 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
 Interaction of Rad22 with Pmt3, Rhp51 and Rpa70. (A) Interaction with Pmt3. (B) Interaction with Rhp51. (C) Interaction with Rpa70. In all cases wild type cells (sp.011) were transformed with plasmids expressing the indicated proteins as tagged fusion proteins under the control of the nmt1 promoter. Protein interactions were investigated using Ni2+ agarose beads, TCA extracts were used as controls to check expression levels. Samples were analysed by SDS-PAGE and western blotted with anti-myc or anti-HA antisera as indicated. *, New HA-cross-reacting species.
###end p 43
###begin p 44
###xml 43 44 43 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 361 362 361 362 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 523 524 523 524 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
 Interaction of Rad22 with Hus5 and Pmt3. (A) Bacterial cell lysates were mixed as indicated and proteins were fractionated on glutathione-Sepharose. Proteins binding to glutathione (GST-pull down), crude extract and unbound material (supernatant) were separated by SDS-PAGE and western blotted with anti-His antisera or stained with Coomassie Brilliant Blue. (B) Interaction of Rad22 and Pmt3 was analysed using extracts from cells over-expressing both proteins as in Figure 2A, but in the presence of 6 M guanidine-HCl. (C) Interaction of Rad22 and Pmt3 expressed at wild type levels. Strains used were an integrated myc + His-tagged Rad22 strain (sp.568) and sp.011 as the negative control. Samples were analysed by SDS-PAGE and western blotted with anti-myc or anti-Pmt3 antisera as indicated. Lanes 1-4, 7 and 8 were exposed to X-ray film for 10 s, while lanes 5 and 6 were exposed for 30 min.
###end p 44
###begin p 45
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schizosaccharomyces pombe</italic>
###xml 25 33 25 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 61 62 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 234 235 222 223 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 601 602 583 584 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 603 604 585 586 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
Schizosaccharomyces pombein vitro Pmt3 modification system. (A) Protein components used to establish the assay. Coomassie stain of SDS-PAGE. Lane 1, 4 microg Hus5; lane 2, 10 microg His-Pmt3-GG; lane 3, 1 microg GST-Rad31, GST-Fub2. (B) Modification of PML. Assays were set up as described in the Materials and Methods; all samples were incubated in assay buffer for 2 h at 30degreesC. Lanes 1-7, wild type PML; lanes 8 and 9, PML-3K-R. Lanes 1 and 2, all assay components; lane 3, no Hus5; lane 4, no Pmt3; lane 5, no Rad31 + Fub2; lane 6, no added ATP; lanes 7 and 9, no Hus5, Pmt3, Rad31 and Fub2 (C-E) Testing for modification of Rad22 (C), Rhp51 (D) and Rpa70 (E). Addition of components was as indicated. (C) *, Major Pmt3-modified product; <, minor Pmt3-modified species of 105 kDa.
###end p 45
###begin title 46
ACKNOWLEDGEMENTS
###end title 46
###begin p 47
###xml 103 119 103 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S.pombe in vitro</italic>
###xml 103 110 <span type="species:ncbi:4896">S.pombe</span>
The authors would like to thank F. Lehembre and R. T. Hay for helpful suggestions for establishing the S.pombe in vitro Pmt3 modification system. This work was supported in part by BBSRC grants nos SBD07487 and 85/G13290. N.J.W. was supported by an MRC Quota studentship (G609/88).
###end p 47

